Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept autoinjector versus prefilled syringe satisfaction study in psoriasis
2006-006309-96Phase 3Completed
- Sponsor
- Wyeth
- Start
- Apr 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of etanercept in psoriasis and plaque psoriasis (2 arms), sponsored by Wyeth. Primary endpoint: Primary endpoint: patient satisfaction at week 12 on 0-10 scale. Started Apr 2007; status: completed.
02
Drugs
etanercept
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2006-006309-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006309-96.